259 related articles for article (PubMed ID: 29233263)
1. Discovery of PET radiopharmaceuticals at the academia-industry interface.
Bernard-Gauthier V; Collier TL; Liang SH; Vasdev N
Drug Discov Today Technol; 2017 Nov; 25():19-26. PubMed ID: 29233263
[TBL] [Abstract][Full Text] [Related]
2. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
[TBL] [Abstract][Full Text] [Related]
3. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
Takebe T; Imai R; Ono S
Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
[TBL] [Abstract][Full Text] [Related]
4. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
Dollé F
J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
[TBL] [Abstract][Full Text] [Related]
5. Prospective of ⁶⁸Ga-radiopharmaceutical development.
Velikyan I
Theranostics; 2013 Dec; 4(1):47-80. PubMed ID: 24396515
[TBL] [Abstract][Full Text] [Related]
6. Classics in Neuroimaging: Development of Positron Emission Tomography Tracers for Imaging the GABAergic Pathway.
Murrell E; Pham JM; Sowa AR; Brooks AF; Kilbourn MR; Scott PJH; Vasdev N
ACS Chem Neurosci; 2020 Jul; 11(14):2039-2044. PubMed ID: 32578977
[TBL] [Abstract][Full Text] [Related]
7. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
8. Drug discovery: new models for industry-academic partnerships.
Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
[TBL] [Abstract][Full Text] [Related]
9. Radiopharmaceutical chemistry with iodine-124: a non-standard radiohalogen for positron emission tomography.
Chacko AM; Divgi CR
Med Chem; 2011 Sep; 7(5):395-412. PubMed ID: 21711220
[TBL] [Abstract][Full Text] [Related]
10. Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance.
Zhu S; Mosessian S; Kroeger K; Sadeghi S; Slavik R; Kinloch S; Moore M; Allen-Auerbach M; Czernin J; Phelps M
Mol Imaging Biol; 2020 Apr; 22(2):256-264. PubMed ID: 31240531
[TBL] [Abstract][Full Text] [Related]
11. Spirocyclic Iodonium Ylides for Fluorine-18 Radiolabeling of Non-Activated Arenes: From Concept to Clinical Research.
Chassé M; Pees A; Lindberg A; Liang SH; Vasdev N
Chem Rec; 2023 Sep; 23(9):e202300072. PubMed ID: 37183954
[TBL] [Abstract][Full Text] [Related]
12. From Unorthodox to Established: The Current Status of (18)F-Trifluoroborate- and (18)F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging.
Bernard-Gauthier V; Bailey JJ; Liu Z; Wängler B; Wängler C; Jurkschat K; Perrin DM; Schirrmacher R
Bioconjug Chem; 2016 Feb; 27(2):267-79. PubMed ID: 26566577
[TBL] [Abstract][Full Text] [Related]
13. Are academic drug discovery efforts receiving more recognition with declining industry efficiency?
Bryans JS; Kettleborough CA; Solari R
Expert Opin Drug Discov; 2019 Jul; 14(7):605-607. PubMed ID: 30907161
[No Abstract] [Full Text] [Related]
14. [Consideration on Academia Environments for Creating Medical Innovation].
Iida K; Ishida T; Nishimura N
Yakugaku Zasshi; 2022 Jan; 142(1):75-84. PubMed ID: 34629350
[TBL] [Abstract][Full Text] [Related]
15. Academia-industry symbiosis in organic chemistry.
Michaudel Q; Ishihara Y; Baran PS
Acc Chem Res; 2015 Mar; 48(3):712-21. PubMed ID: 25702529
[TBL] [Abstract][Full Text] [Related]
16. High--valent technetium chemistry-new opportunities for radiopharmaceutical developments.
Braband H
J Labelled Comp Radiopharm; 2014 Apr; 57(4):270-4. PubMed ID: 24347394
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology.
Pisaneschi F; Viola NT
Mol Imaging Biol; 2022 Feb; 24(1):1-7. PubMed ID: 34542804
[TBL] [Abstract][Full Text] [Related]
18. Method to Development of PET Radiopharmaceutical for Cancer Imaging.
Damuka N; Solingapuram Sai KK
Methods Mol Biol; 2022; 2413():13-22. PubMed ID: 35044650
[TBL] [Abstract][Full Text] [Related]
19. Radiotracers for positron emission tomography imaging.
Gillings N
MAGMA; 2013 Feb; 26(1):149-58. PubMed ID: 23242769
[TBL] [Abstract][Full Text] [Related]
20. Classics in Neuroimaging: Imaging the Cholinergic System with Positron Emission Tomography.
Sowa Dumond AR; Gross HK; Bohnen NI; Kanel P; Müller MLTM; Koeppe RA; Kilbourn MR; Scott PJH
ACS Chem Neurosci; 2021 May; 12(9):1472-1479. PubMed ID: 33890459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
